← Eichor
Study identifier: NCT04996823 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Axitinib + Ipilimumab in Advanced Melanoma

Condition: Melanoma  ·  Sponsor: H. Lee Moffitt Cancer Center and Research Institute

PhasePhase 2
Planned participants25
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical research study is to find out if taking axitinib with ipilimumab is effective in treating advanced melanoma.

This description comes directly from the study's public registry record.

Talk to the study team

Arnay Marshall  ·  813-745-5938  ·  Arnay.Marshall@moffitt.org

Always discuss trial participation with your own doctor first.

Locations (1)

Moffitt Cancer CenterTampa, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04996823